Neuropeptide S receptor gene variant and environment: Contribution to alcohol use disorders and alcohol consumption

Addiction Biology

Volumn 20, Issue 3, 2015, Pages 605-616

  Laas, Kariina ^a   Reif, Andreas ^b,c   Akkermann, Kirsti ^a   Kiive, Evelyn ^a   Domschke, Katharina ^b   Lesch, Klaus Peter ^b,c,d   Veidebaum, Toomas ^e   Harro, Jaanus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e National Institute for Heath Development   (Estonia)

Author keywords

Addiction; alcohol; impulsivity; neuropeptide S; NPSR1; personality

Indexed keywords

NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S RECEPTOR; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE S, HUMAN; NPSR1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PERSONALITY; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SUBSTANCE ABUSE; YOUNG ADULT; COMPLICATION; DRINKING BEHAVIOR; ENVIRONMENT; FAMILY RELATION; GENETICS; HETEROZYGOTE; IMPULSIVENESS; MENTAL STRESS; PHYSIOLOGY;

ADOLESCENT; ADULT; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; CHILD; ENVIRONMENT; FAMILY RELATIONS; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; IMPULSIVE BEHAVIOR; MALE; NEUROPEPTIDES; PERSONALITY; POLYMORPHISM, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84926520736     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12149     Document Type: Article

References (48)

1. Acton GS, (2003) Measurement of impulsivity in a hierarchical model of personality traits: implications for substance use. Subst Use Misuse 38: 67-83.
2. Badia-Elder NE, Henderson AN, Bertholomey ML, Dodge NC, Stewart RB, (2008) The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and nonpreferring rats. Alcohol Clin Exp Res 32: 1380-1387.
3. Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Mass M, Ciccocioppo R, (2009) Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 34: 2125-2134.
4. Cannella N, Kallupi M, Ruggeri B, Ciccocioppo R, Ubaldi M, (2013) The role of neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission. Prog Neurobiol 100: 48-59.
5. Cao J, de Lecea L, Inemoto S, (2011) Intraventricular administration of neuropeptide S has reward-like effects. Eur J Pharmacol 658: 16-21.
6. Chartier KG, Hesselbrock MN, Hesselbrock VM, (2010) Development and vulnerability factors in adolescent alcohol use. Child Adolesc Psychiatr Clin N Am 19: 493-504.
7. Dannlowski U, Kugel H, Franke F, Stuhrmann A, Hohoff C, Zwanzger P, Lenzen T, Grotegerd D, Suslow T, Arolt V, Heindel W, Domschke K, (2011) Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacology 36: 1879-1885.
8. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J, (2011) Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Mol Psychiatry 16: 938-948.
9. Donner J, Haapakoski R, Ezer S, Melén E, Pirkola S, Gratacòs M, Zucchelli M, Anedda F, Johansson LE, Söderhäll C, Orsmark-Pietras C, Suvisaari J, Martín-Santos R, Torrens M, Silander K, Terwilliger JD, Wickman M, Pershagen G, Lönnqvist J, Peltonen L, Estivill X, D'Amato M, Kere J, Alenius H, Hovatta I, (2010) Assessment of the neuropeptide S system in anxiety disorders. Biol Psychiatry 68: 474-483.
10. Enquist J, Ferwerda M, Madhavan A, Hok D, Whistler JL, (2012) Chronic ethanol potentiates the effect of neuropeptide S in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects. Neuropsychopharmacology 37: 2436-2445.
11. Ersche KD, Turton AJ, Pradhan S, Bullmore ET, Robbins TW, (2010) Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry 68: 770-773.
12. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K, (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry 61: 807-816.
13. Harro J, Merenäkk L, Nordquist N, Konstabel K, Comasco E, Oreland L, (2009) Personality and the serotonin transporter gene: associations in a longitudinal population-based study. Biol Psychol 81: 9-13.
14. Harro M, Eensoo D, Kiive E, Merenäkk L, Alep J, Oreland L, Harro J, (2001) Platelet monoamine oxidase in healthy 9- and 15-years old children: the effect of gender, smoking and puberty. Prog Neuropsychopharmacol Biol Psychiatry 25: 1497-1511.
15. Heilig M, Koob GF, (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399-406.
16. Iacono WG, Malone SM, McGue M, (2003) Substance use disorders, externalizing psychopathology, and P300 event related potential amplitude. Int J Psychophysiol 48: 147-178.
17. Kallasmaa T, Allik J, Realo A, McCrae RR, (2000) The Estonian version of the NEOPI-R: an examination of universal and culture-specific aspects of the five-factor model. Eur J Pers 14: 265-278.
18. 2A-adrenoceptor C-1291G genotype and maltreatment on hyperactivity and inattention in adolescents. Prog Neuropsychopharmacol Biol Psychiatry 34: 219-224.
19. Klauke B, Deckert J, Zwanzger P, Baumann C, Arolt V, Pauli P, Reif A, Domschke K, (2014) Neuropeptide S receptor gene (NPSR) and life events: G × E effects on anxiety sensitivity and its subdimensions. World J Biol Psychiatry 15: 17-25.
20. af Klinteberg B, Oreland L, (1995) Hyperactive and aggressive behaviors in childhood as related to low platelet monoamine oxidase (MAO) activity at adult age: a longitudinal study of male subjects. Pers Individ Dif 19: 373-383.
21. Kushner MG, Wall MM, Krueger RF, Sher KJ, Maurer E, Thuras P, Lee S, (2012) Alcohol dependence is related to overall internalizing psychopathology load rather than to particular internalizing disorders: evidence from a national sample. Alcohol Clin Exp Res 36: 325-331.
22. Laas K, Reif A, Herterich S, Eensoo D, Lesch K-P, Harro J, (2010) The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity. Psychopharmacology (Berl) 209: 255-261.
23. 107Ile variant and environment: contribution to affective and anxiety disorders, and suicidal behaviour. Int J Neuropsychopharmacol 17: 541-552.
24. Laas K, Reif A, Kiive E, Domschke K, Lesch K-P, Veidebaum T, Harro J, (2014b) A functional NPSR1 gene variant and environment shape personality and impulsive action: a longitudinal study. J Psychopharmacol 28: 227-236.
25. Lukas M, Neumann ID, (2012) Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects. Neuropharmacology 62: 398-405.
26. Lyvers M, Hasking P, Hani R, Rhodes M, Trew E, (2010) Drinking motives, drinking restraint and drinking behaviour among young adults. Addict Behav 35: 116-122.
27. 2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study. Psychopharmacology (Berl) 215: 13-22.
28. Mochizuki T, Kim J, Sasaki K, (2010) Microinjection of neuropeptide S into the rat ventral tegmental area induces hyperactivity and increases extracellular levels of dopamine metabolites in the nucleus accumbens shell. Peptides 31: 926-931.
29. Mohr CD, Brannan D, Wendt S, Jacobs L, Wright R, Wang M, (2013) Daily mood-drinking slopes as predictors: a new take on drinking motives and related outcomes. Psychol Addict Behav 27: 944-955.
30. Mõttus R, Pullmann H, Allik J, (2006) Towards more readable Big Five personality inventories. Eur J Psychol Assess 22: 149-157.
31. Okamura N, Hashimoto K, Iyo M, Shimizu E, Dempfle A, Friedel S, Reinscheid RK, (2007) Gender-specific association of a functional coding polymorphism in the neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 31: 1444-1448.
32. Paaver M, Kurrikoff T, Nordquist N, Oreland L, Harro J, (2008) The effect of 5-HTT gene promoter polymorphism on impulsivity depends on family relations in girls. Prog Neuropsychopharmacol Biol Psychiatry 32: 1263-1268.
33. Raczka KA, Gartmann N, Mechias M-L, Reif A, Büchel C, Deckert J, Kalisch R, (2010) A neuropeptide S receptor variant associated with overinterpretation of fear reactions: a potential neurogenetic basis for catastrophizing. Mol Psychiatry 15: 1067-1074.
34. Raiteri L, Luccini E, Romei C, Salvadori S, Calõ G, (2009) Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings. Br J Pharmacol 157: 474-481.
35. Reif A, Kiive E, Kurrikoff T, Paaver M, Herterich S, Konstabel K, Tulviste T, Lesch K-P, Harro J, (2011) A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity. Psychopharmacology (Berl) 214: 239-248.
36. Reinscheid RK, (2008) Neuropeptide S: anatomy, pharmacology, genetics and physiological functions. Results Probl Cell Differ 46: 145-158.
37. Reinscheid RK, Xu YL, Okamura N, Zeng J, Chung S, Pai R, Wang Z, Civelli O, (2005) Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther 315: 1338-1345.
38. Rizzi A, Vergura R, Marzola G, Ruzza C, Guerrini R, Salvadori S, Regoli D, Calo G, (2008) Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol 154: 471-479.
39. Ruggeri B, Braconi S, Cannella N, Kallupi M, Soverichia L, Ciccocioppo R, Ubaldi M, (2010) Neuropeptide S receptor gene expression in alcohol withdrawal and protracted abstinence in postdependent rats. Alcohol Clin Exp Res 34: 90-97.
40. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta E, Baker T, Dunbar GC, (1998) The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-VI and ICD-10. J Clin Psychiatry 59: 22-33.
41. Shlik J, Aluoja A, Kihl E, (1999) MINI 5.0.0. Mini rahvusvaheline neuropsühhiaatriline intervjuu DSM-IV. Eesti versioon.
42. Si W, Aluisio L, Okamura N, Clark SD, Fraser I, Sutton SW, Bonaventure P, Reinscheid RK, (2010) Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex. J Neurochem 115: 475-482.
43. Tomson K, Merenäkk L, Loit H-M, Mäestu J, Harro J, (2011) The relationship between serotonin transporter gene promoter polymorphism and serum lipid levels at young age in a longitudinal population-representative study. Prog Neuropsychopharmacol Biol Psychiatry 35: 1857-1862.
44. Tupak SV, Reif A, Pauli P, Dresler T, Herrmann MJ, Domschke K, Jochum C, Haas E, Baumann C, Weber H, Fallgatter AJ, Deckert J, Ehlis A-C, (2013) Neuropeptide S receptor gene: fear-specific modulations of prefrontal activation. Neuroimage 66: 353-360.
45. von Diemen L, Bassani DG, Fuchs SC, Szobot CM, Pechansky F, (2008) Impulsivity, age of first alcohol use and substance use disorders among male adolescents: a population cased case-control study. Addiction 103: 1198-1205.
46. Vengeliene V, Bilbao A, Molander A, Spanagel R, (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154: 299-315.
47. Witt E, (2007) Puberty, hormones, and sex differences in alcohol abuse and dependence. Neurotoxicol Teratol 29: 81-95.
48. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O, (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43: 487-497.